Hawkins, Inc. HWKN logged earnings of 72 cents per share within the third quarter of fiscal 2025 (ended Dec. 29, 2024), up from 71 cents within the year-ago quarter. Earnings within the reported quarter missed the Zacks Consensus Estimate of 78 cents.
Discover the newest EPS estimates and surprises on Zacks Earnings Calendar.
The corporate registered revenues of $226.2 million for the quarter, up round 8% 12 months over 12 months. It beat the Zacks Consensus Estimate of $219.2 million. Larger gross sales within the Water Therapy unit greater than offset the decline within the Industrial section.
Hawkins, Inc. Value, Consensus and EPS Shock
Hawkins, Inc. price-consensus-eps-surprise-chart | Hawkins, Inc. Quote
Hawkins’ Phase Highlights
Gross sales from the Water Therapy section climbed 22% 12 months over 12 months to $99.8 million. Gross sales have been pushed by added gross sales from acquired companies and better gross sales volumes within the legacy enterprise. The section benefited from the seven acquisitions that HWKN accomplished over the previous 18 months.
Industrial section gross sales fell 1% 12 months over 12 months to $92 million within the reported quarter. Gross sales within the section have been affected by lowered promoting costs on sure merchandise resulting from decrease uncooked materials prices and product combine modifications.
Well being and Vitamin section gross sales elevated 3% 12 months over 12 months to $34.5 million. The upside was pushed by increased gross sales of manufactured merchandise.
HWKN’s Financials
The corporate ended the quarter with money and money equivalents of roughly $8.3 million, up round 10% sequentially. Lengthy-term debt was roughly $103.9 million on the finish of the quarter, up round 11% from the prior quarter.
HWKN generated an working money stream of round $80.3 million for the 9 months ended Dec. 29, 2024.
Hawkins’ Outlook
Shifting forward, HWKN expects sustained development within the Water Therapy and Well being and Vitamin segments. It expects the Industrial section to carry out just like the primary 9 months of fiscal 2025.
HWKN’s Value Efficiency
Shares of Hawkins have rallied 89.9% in a 12 months in contrast with the Zacks Chemicals Specialty trade’s decline of 14.5%.
Picture Supply: Zacks Funding Analysis
HWKN’s Zacks Rank & Different Key Picks
HWKN at the moment carries a Zacks Rank #3 (Maintain).
Higher-ranked shares within the Fundamental Supplies area are Ingevity Company NGVT, ICL Group Ltd ICL and Nutrien Ltd. NTR. Whereas NGVT carries a Zacks Rank #1 (Sturdy Purchase), ICL and NTR have a Zacks Rank #2 (Purchase). You may see the complete list of today’s Zacks #1 Rank stocks here.
Ingevity is scheduled to launch fourth-quarter outcomes on Feb.18. The Zacks Consensus Estimate for NGVT’s fourth-quarter earnings is pegged at 12 cents. NGVT surpassed the Zacks Consensus Estimate in three of the trailing 4 quarters whereas lacking as soon as. It has a trailing four-quarter earnings shock of 95.4%, on common.
ICL Group is slated to launch fourth-quarter outcomes on Feb.26. The consensus estimate for ICL’s fourth-quarter earnings is pegged at 6 cents. It surpassed the Zacks Consensus Estimate for earnings in every of the final 4 quarters at a median of 18.1%.
Nutrien is scheduled to launch fourth-quarter outcomes on Feb.19. The Zacks Consensus Estimate for NTR’s fourth-quarter earnings is pegged at 33 cents. NTR has gained round 2% prior to now 12 months.
Analysis Chief Names “Single Finest Choose to Double”
From 1000’s of shares, 5 Zacks consultants every have chosen their favourite to skyrocket +100% or extra in months to return. From these 5, Director of Analysis Sheraz Mian hand-picks one to have essentially the most explosive upside of all.
This firm targets millennial and Gen Z audiences, producing almost $1 billion in income final quarter alone. A latest pullback makes now a really perfect time to leap aboard. After all, all our elite picks aren’t winners however this one may far surpass earlier Zacks’ Shares Set to Double like Nano-X Imaging which shot up +129.6% in little greater than 9 months.
Free: See Our Top Stock And 4 Runners Up
ICL Group Ltd. (ICL) : Free Stock Analysis Report
Ingevity Corporation (NGVT) : Free Stock Analysis Report
Hawkins, Inc. (HWKN) : Free Stock Analysis Report
Nutrien Ltd. (NTR) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.
